专利检索 ap:("Crozet Medical GmbH") AND inv:"Juergen SCHRADER" 第 1 页

1.

发明申请
TARGETED DELIVERY OF NANOPARTICLES TO EPICARDIAL DERIVED CELLS (EPDC) 审中-公开
标题翻译：将纳米颗粒定向递送至EPICARDI衍生细胞（EPDC）

公开(公告)号：US20160030600A1

公开(公告)日：2016-02-04

申请号：US14772668

申请日：2014-03-06

申请人： Crozet Medical GmbH

发明人： Juergen SCHRADER

IPC分类号： A61K49/00 , A61K35/34 , A61K9/51 , G01N33/50 , A61K51/12

CPC分类号： A61K49/0093 , A61K9/51 , A61K35/34 , A61K49/1812 , A61K49/186 , A61K51/1244 , G01N33/5091

摘要： This invention relates to nanoparticles for use in the in vivo diagnostics of epicardial derived cells (EPDCs) to nano particles for use in the treatment of cardiac injury. The invention further relates to a method for analyzing EPDCs, to a method for labeling EPDCs, and to a method for transferring a therapeutic agent into an EPDC.

摘要翻译： 本发明涉及用于体外诊断心外膜衍生细胞（EPDCs）的纳米颗粒用于治疗心脏损伤的纳米颗粒。本发明还涉及分析EPDCs的方法，EPDCs的标记方法和将治疗剂转移到EPDC中的方法。